1.1 Introduction
Tuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs but capable of spreading to other parts of the body if left untreated. According to the World Health Organization (2024), tuberculosis remains one of the leading infectious causes of illness and death worldwide despite the availability of effective prevention and treatment measures. Human Immunodeficiency Virus (HIV), on the other hand, is a virus that attacks the body's immune system, reducing its ability to fight infections and diseases. If HIV is not properly managed with antiretroviral therapy, it can progress to Acquired Immunodeficiency Syndrome (AIDS), a stage characterized by severe immune suppression and increased susceptibility to opportunistic infections (UNAIDS, 2023).
Tuberculosis and HIV are closely linked because HIV significantly weakens the immune system, making infected individuals more vulnerable to developing active tuberculosis. Similarly, tuberculosis is one of the leading causes of death among people living with HIV due to their reduced ability to fight bacterial infections. According to the World Health Organization (2024), people living with HIV are several times more likely to develop active tuberculosis than individuals without HIV.
As a prelude to other parts of this study, this chapter will discuss the background upon which this study was initiated, the statement of problems that led to this study, the aim and objectives of the study. Others are significance of the study, scope of work, research hypothesis and questions, limitation of the study and definition of terms.
1.2 Background of Study
Historically, tuberculosis (TB) dates back thousands of years, making it one of the oldest known infectious diseases affecting humans. According to Daniel (2006), evidence of tuberculosis has been found in ancient Egyptian mummies, indicating that the disease existed long before modern civilization. Historically, tuberculosis was commonly referred to as "consumption" because infected individuals experienced severe weight loss and prolonged coughing. Before the discovery of effective antibiotics, tuberculosis was responsible for millions of deaths worldwide and was regarded as one of the deadliest infectious diseases of the nineteenth and early twentieth centuries (Daniel, 2006).
Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) remain two of the most significant infectious diseases affecting global public health. According to the World Health Organization (2024), tuberculosis is an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs but may also spread to other organs of the body. HIV is a virus that attacks the immune system by destroying CD4 cells, thereby reducing the body's ability to resist infections and diseases. According to the Joint United Nations Programme on HIV/AIDS (2023), HIV infection progresses gradually and, without effective treatment, can lead to Acquired Immunodeficiency Syndrome (AIDS), making infected individuals highly vulnerable to opportunistic infections such as tuberculosis. The interaction between these two diseases has created a major health challenge because HIV weakens immunity while tuberculosis takes advantage of the weakened immune system, resulting in severe illness, prolonged treatment, and increased mortality.
Similarly, according to Frieden, Sterling, Munsiff, Watt, and Dye (2003), tuberculosis remains one of the most common opportunistic infections among people living with HIV, particularly in countries with high HIV prevalence. In the same vein, according to Corbett et al. (2003), HIV infection has significantly contributed to the resurgence of tuberculosis in many developing countries because immunocompromised individuals are more likely to develop active TB after exposure.
Likewise, according to Getahun et al. (2010), early identification and integrated treatment of both infections improve patient survival and reduce disease transmission within communities. Furthermore, according to the World Health Organization (2024), tuberculosis remains one of the leading infectious causes of death worldwide despite being preventable and curable. The report stated that millions of new TB cases are recorded every year, with a substantial proportion occurring among people living with HIV. Moreover, according to UNAIDS (2023), advances in antiretroviral therapy have significantly improved the quality of life of people living with HIV, yet tuberculosis continues to account for a large number of HIV-related deaths globally.
Correspondingly, according to Centers for Disease Control and Prevention (2024), individuals infected with HIV are several times more likely to develop active tuberculosis than those without HIV because of their weakened immune response. Additionally, according to Lawn and Churchyard (2009), tuberculosis and HIV co-infection creates a complex clinical condition because both diseases accelerate each other's progression. Supporting this position, according to Pawlowski et al. (2012), tuberculosis develops more rapidly among HIV-positive individuals due to impaired immune function, while TB infection may also worsen HIV disease progression by increasing viral replication. Relatedly, according to Harries, Dye, and Williams (2010), effective management of co-infection depends on early diagnosis, prompt initiation of antiretroviral therapy, appropriate tuberculosis treatment, and continuous patient monitoring.
The effects of tuberculosis and HIV co-infection extend beyond individual health outcomes. According to Lönnroth et al. (2010), co-infection contributes to reduced productivity, increased healthcare expenditure, prolonged hospitalization, psychological distress, family hardship, and reduced quality of life. Likewise, according to WHO (2024), successful control of Tuberculosis and Human Immunodeficiency Virus requires collaboration between governments, healthcare providers, communities, and international organizations through sustained prevention, early diagnosis, treatment adherence, and continuous public health education.
This study is set against the backdrop of the persistent burden of tuberculosis and HIV co-infection among adolescents and adults, the continuing challenges affecting timely diagnosis and treatment, and the need to generate local evidence that will support effective public health interventions in Yala Local Government Area, Cross River State.
1.3 Statement of Problems
Investigation revealed that tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection remains a serious public health problem among adolescents and adults, especially in developing countries where access to quality healthcare, early diagnosis, and continuous treatment is still limited. On the other hand, many infected individuals are diagnosed late because the symptoms of tuberculosis are often mistaken for other illnesses, while fear of stigma discourages many people from seeking timely medical attention. HIV weakens the immune system, making infected individuals more vulnerable to tuberculosis infection and increasing the risk of severe illness and death if appropriate care is not received promptly (World Health Organization [WHO], 2024).
Additionally, the burden of TB and HIV co-infection continues to affect families, communities, and health facilities through increased hospitalization, treatment costs, reduced productivity, and avoidable deaths. Although national and international health programmes have introduced strategies to control TB and HIV, evidence suggests that many communities still experience challenges related to treatment adherence, delayed diagnosis, inadequate screening, and limited integration of TB and HIV services (Joint United Nations Programme on HIV/AIDS [UNAIDS], 2023).
Furthermore, there is limited documented evidence focusing specifically on the effects of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area of Cross River State. It is against this backdrop that this study seeks to examine the effects of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area, Cross River State.
1.4 Aim and Objectives of Study
The aim of this study is to examine the effects of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area, Cross River State. The specific objectives of this research are to:
- Determine the health effects of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
- Examine the factors contributing to tuberculosis and HIV co-infection among adolescents and adults in the study area.
- Assess the level of awareness of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
- Identify the challenges affecting the management of tuberculosis and HIV co-infection in the study area.
- Determine the strategies for improving the prevention and management of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
1.5 Research Questions
The study came up with research questions so as to be able to ascertain the above stated objectives. The following research questions will guide the study:
- What are the health effects of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area?
- What factors contribute to tuberculosis and HIV co-infection among adolescents and adults in the study area?
- What is the level of awareness of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area?
- What challenges affect the management of tuberculosis and HIV co-infection in the study area?
- What strategies can improve the prevention and management of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area?
1.6 Research Hypotheses
In order to pursue the objective of this study, the following generalized statements have been designed to guide and aids in obtaining the result for the experiment to be conducted. For this work, the null hypothesis will be represented with H0 while the alternative hypothesis will be represented with hypothesis H1.
Hypothesis One
- H0: There is no significant relationship between tuberculosis and HIV co-infection and the health status of adolescents and adults in Yala Local Government Area.
- H1: There is a significant relationship between tuberculosis and HIV co-infection and the health status of adolescents and adults in Yala Local Government Area.
Hypothesis Two
- H0: Factors contributing to tuberculosis and HIV co-infection do not significantly influence the occurrence of co-infection among adolescents and adults in Yala Local Government Area.
- H1: Factors contributing to tuberculosis and HIV co-infection significantly influence the occurrence of co-infection among adolescents and adults in Yala Local Government Area.
Hypothesis Three
- H0: The level of awareness does not significantly influence the prevention of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
- H1: The level of awareness significantly influences the prevention of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
Hypothesis Four
- H0: The challenges affecting the management of tuberculosis and HIV co-infection do not significantly affect treatment outcomes among adolescents and adults in Yala Local Government Area.
- H1: The challenges affecting the management of tuberculosis and HIV co-infection significantly affect treatment outcomes among adolescents and adults in Yala Local Government Area.
Hypothesis Five
- H0: The identified prevention and management strategies do not significantly reduce tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
- H1: The identified prevention and management strategies significantly reduce tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area.
1.7 Significance of Study
It is believed that at the completion of this research, the findings will provide useful information for improving the prevention and management of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area. The study will also support healthcare providers with evidence for strengthening early diagnosis, integrated treatment, and patient follow-up.
Furthermore, the findings will assist health authorities in planning effective public health programmes aimed at reducing tuberculosis and HIV co-infection. It will also improve public awareness of the health effects of tuberculosis and HIV co-infection and encourage timely use of healthcare services.
Lastly, the outcome of this research will contribute to academic knowledge by serving as reference material for future studies on communicable diseases.
1.8 Scope of Study
This study focuses on the effects of tuberculosis and HIV co-infection among adolescents and adults in Yala Local Government Area of Cross River State, Nigeria. The study covers the health effects of tuberculosis and HIV co-infection, factors contributing to co-infection, level of awareness, challenges affecting disease management, and strategies for improving prevention and treatment.
Information will be obtained from adolescents and adults as well as selected healthcare facilities under the supervision of the Cross River State Ministry of Health.
1.9 Limitations of the Study
During the course of this study, there were some problems encountered which stood as limitations to the research work. Some of the limitations include:
- Time Constraint: The time frame given to accomplish this project was very short due to school academic calendar and it was carried out under pressure which made the researcher not to implement some necessary features.
- Financial Constraint: Insufficient fund tends to impede the efficiency of the researcher in sourcing for the relevant materials, literature or information and in the process of data collection (internet, questionnaire and interview).
- Initial Cooperation Delay from Respondents: A particular limitation of this work came as a result of the respondent refusal to offer their cooperation at the initial time they were contacted. This contributed in making the success of this research study difficult.
1.10 Definition of Terms
Tuberculosis (TB):
Tuberculosis is a contagious bacterial disease caused by Mycobacterium tuberculosis that mainly affects the lungs but may spread to other parts of the body if not properly treated (World Health Organization, 2024).
Human Immunodeficiency Virus (HIV):
HIV is a virus that attacks the body's immune system, reducing its ability to fight infections and diseases. Without proper treatment, HIV may progress to Acquired Immunodeficiency Syndrome (UNAIDS, 2023).
Co-infection:
Co-infection refers to the condition in which an individual is infected with tuberculosis and HIV at the same time, making disease management more difficult and increasing the risk of poor health outcomes (WHO, 2024).
Adolescents:
Adolescents are individuals between the ages of 10 and 19 years who experience physical, emotional, and social development during the transition from childhood to adulthood (World Health Organization, 2023).
Adults:
Adults are individuals aged 20 years and above who have attained maturity and are responsible for making independent personal, social, and economic decisions.
Health Effects:
Health effects refer to the physical, psychological, and social consequences experienced by individuals as a result of tuberculosis and HIV co-infection.
…